Skip to content

Efficiency of a new vibrator device in comparision to an ultrasound device for managing a muscle pain disorder ââ?¬â?? a randomized clinical trial

Efficacy of a novel vibrator device in comparision to ultrasonic device for the management of myofascial pain dysfunction syndrome- a randomized clinical trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025824
Enrollment
52
Registered
2020-06-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

Intervention1: vibration therapy using novel vibrator device: experimental group suffering from myofascial pain dysfunction syndrome will be treated with vibrator therapy using novel vibrator device C

Sponsors

Govt Dental College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients who are willing to participate 2. Patients who have experienced chronic and intermittent myofascial pain for a time period of 1 month or more 3. Patients meeting Laskinââ?¬•s criteria for MPDS

Exclusion criteria

Exclusion criteria: 1. History of recent trauma 2. Patients who are receiving any medication or treatment other than vibration therapy and ultrasound therapy 3. Patients with gross malocclusion 4. History of TMJ pathology such as internal derangement or disc pathology and any invasive procedure on TMJ 5. Patients with uncontrolled Diabetes Mellitus 6. Neurological disorders such as trigeminal neuralgia 7. Any previous history of adverse reaction to vibration therapy

Design outcomes

Primary

MeasureTime frame
1. To assess the efficacy of our novel vibrator device 2. To compare our device with ultrasonography Timepoint: -Preoperatively, -Intaoperatively weekly for 4 weeks -Postoperatively after 3 months and 6 months for followup

Secondary

MeasureTime frame
1. To find out any discomfort or untoward response experienced by the patient in both modalities 2. To assess the feasibility outcomes of both modalities 3.To assess the cost-effectiveness of both modalities Timepoint: -Preoperatively, -Intaoperatively weekly for 4 weeks -Postoperatively after 3 months and 6 months for followup

Countries

India

Contacts

Public ContactDr Prajwalit Kende

Govt Dental College and Hospital Mumbai

prajwalitkende1979@gmail.com9324715824

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026